EUVIMEDEUVIMED entdecken
Vergleichsstudie

Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy

Marta Albanell-Fernández iD, Ángela Pérez Sánchez, Inés Monge-Escartín, Gisela Riu-Viladoms iD, Mª Carmen Rodríguez Mues, Mª Lourdes Corominas Bosch, Lydia Gaba García, Neus Basté Rollán, Noemí Reguart, Dolors Soy Muner, Esther Carcelero San Martín

Journal of Oncology Pharmacy Practice · 2024

DOI: 10.1177/10781552231194077 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Oncology Pharmacy Practice, 2024. Verfasst von Marta Albanell-Fernández und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Carboplatin, Antiemetics, Nausea, Dexamethasone. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chemotherapy-induced nausea and vomiting (CINV) is one of the adverse events that most affects oncologic patients’ quality of life. Carboplatin AUC ≥ 4 belongs to agents with high emetic risk (moderate risk in ASCO guidelines). We aimed to compare the effectiveness of netupitant/palonosetron and dexamethasone triple combination (TC) therapy versus ondansetron and dexamethasone double combination (DC) therapy as antiemetic prophylaxis in patients with carboplatin AUC ≥ 4. As a secondary endpoint, in TC group we evaluated the effectiveness of changing NEPA administration timing from 1 h to 15 min before chemotherapy.

Methods

Open-label prospective study conducted in a tertiary-care hospital in patients receiving carboplatin AUC ≥ 4. CINV was evaluated using MASCC antiemetic tool, in acute (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarboplatinAntiemeticsNauseaDexamethasoneVomitingOndansetronHumansProspective StudiesMaleMiddle AgedFemaleAgedPalonosetronAdultAntineoplastic AgentsDrug Therapy, CombinationNeoplasmsQuality of LifeAntineoplastic Combined Chemotherapy ProtocolsDrug Combinations

Stichwörter der Autor:innen

AntiemeticsCINVcarboplatinnetupitant–palonosetronsupportive care

Substanzen

CarboplatinAntiemeticsDexamethasoneOndansetronPalonosetronAntineoplastic AgentsDrug Combinations

Autor:innen und Institutionen

  • Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
  • August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Department of Pharmacology, Toxicology and Therapeutic Chemistry, School of Pharmacy, University of Barcelona, Barcelona, Spain.

ORCID-Profile: Marta Albanell-Fernández, Gisela Riu-Viladoms

Zitieren

APA

Albanell-Fernández, M., Pérez Sánchez, Á., Monge-Escartín, I., Riu-Viladoms, G., Rodríguez Mues, M. C., Corominas Bosch, M. L., Gaba García, L., Rollán, N. B., Reguart, N., Soy Muner, D., & Carcelero San Martín, E. (2024). Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231194077

Vancouver

Albanell-Fernández M, Pérez Sánchez Á, Monge-Escartín I, Riu-Viladoms G, Rodríguez Mues MC, Corominas Bosch ML, et al. Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy. Journal of Oncology Pharmacy Practice. 2024. doi:10.1177/10781552231194077

BibTeX
@article{AlbanellFernndez2024,
  author = {Albanell-Fernández, Marta and Pérez Sánchez, Ángela and Monge-Escartín, Inés and Riu-Viladoms, Gisela and Rodríguez Mues, Mª Carmen and Corominas Bosch, Mª Lourdes and Gaba García, Lydia and Rollán, Neus Basté and Reguart, Noemí and Soy Muner, Dolors and Carcelero San Martín, Esther},
  title = {Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2024},
  doi = {10.1177/10781552231194077}
}
Kostenlos starten →